Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Oral DHEA administration to patients with hypoadrenalism, in addition to glucocorticoid and mineralcorticoid replacement, may improve both well-being and hormonal/metabolic parameters. Twenty patients (13 men, 7 women, 26-76 yr, 11 with Addison's disease, 9 with central hypoadrenalism) were recruited in a placebo-controlled, randomized study. Hormone levels, carbohydrate and lipid parameters, bone metabolism, body composition and psychological parameters were evaluated at baseline and after treatment with DHEA 50 mg/day or placebo for 4 months. After 4 months of DHEA administration, serum DHEAS levels raised both in men (from 0.71+/-0.18 to 8.28+/-1.66 micropmol/l, p<0.005) and in women (from 0.25+/-0.07 to 5.65+/-1.93 micromol/l, p<0.05). Only in hypoadrenal women an increase in testosterone (T; from 0.4+/-0.1 to 1.45+/-0.26 nmol/l, p<0.05) and androstenedione (A; from 0.86+/-0.34 to 2.05+/-0.29 nmol/l, p<0.05) levels was observed. In men no significant modifications in T and 17-hydroxyprogesterone (17-OHP) levels were found, whereas serum SHBG significantly decreased. As far as the metabolic parameters are concerned, only in patients with Addison's disease a significant decrease in total cholesterol and in low-density lipoproteins after 4 months of DHEA administration was found. No changes in glucose metabolism and insulin sensitivity were observed. In basal conditions, mean serum osteocalcin (OC) was normal and significantly decreased after DHEA treatment. A significant re…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which is in keeping with observations in some short- (20,48,54) and longer-term trials (25) but differs from observations in women with primary or secondary adrenal failure (23,24).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [48]
In the citing paper
“The mechanism by which increased lean muscle mass occurs is not known, but it is noteworthy that there was no associated diminution in fat mass as has been reported by other groups after DHEA supplementation (48,49).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [48]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 3,800
The Mini-Mental State Examination
Folstein, M. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060110016 · Cited by 1,936
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
The psychosocial adjustment to illness scale (PAIS)
Derogatis, L. R. (1986) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(86)90069-3 · Cited by 621
Morales, A. J., Haubrich, R. H., Hwang, J. Y., Asakura, H., & Yen, S. S. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00507.x · Cited by 418
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Cited by
Androgen therapy in women: An Endocrine Society clinical practice guideline
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1121 · Cited by 301
Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282
Androgen Actions and the Ovary
Walters, K. A., Allan, C. M., & Handelsman, D. J. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.064089 · Cited by 258
“Clinical evidence for a physiological role of androgens in human female health comes from findings that women with complete adrenal failure exhibit clinical benefits after replacement of dehydroepiandrosterone (DHEA) in some [5, 6], but not all [7, 8], studies, and women respond well to the pharmacological use of T an…”
BackgroundDehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME)
Traish, A. M., Kang, H. P., Saad, F., & Guay, A. T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02523.x · Cited by 234
Miller, K. K., Biller, B. M. K., Beauregard, C., Lipman, J. G., Jones, J., Schoenfeld, D., Sherman, J. C., Swearingen, B., Loeffler, J., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2596 · Cited by 225
Labrie, F., Archer, D., Bouchard, C., Fortier, M., Cusan, L., Gomez, J.-L., Girard, G., Baron, M., Ayotte, N., Moreau, M., et al. (2009) · Menopause · doi:10.1097/gme.0b013e31819e85c6 · Cited by 191
“The median range age of women was 58 (49-70), 57 (42-72), 58 (50-74), and 59 (46-69) years in the four groups.”
Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial
Gurnell, E. M., Hunt, P. J., Curran, S. E., Conway, C. L., Pullenayegum, E. M., Huppert, F. A., Compston, J. E., Herbert, J., & Chatterjee, V. K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1134 · Cited by 189
“Finally, we observed no changes in sexual function after DHEA treatment, which is in keeping with observations in some short- (20, 48, 54) and longer-term trials (25) but differs from observations in women with primary or secondary adrenal failure (23, 24).”
BackgroundResultDHEA, Important Source of Sex Steroids in Men and Even More in Women
Labrie, F. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 183
Direct Agonist/Antagonist Functions of Dehydroepiandrosterone
Chen, F., Knecht, K., Birzin, E., Fisher, J., Wilkinson, H., Mojena, M., Moreno, C. T., Schmidt, A., Harada, S.-I., Freedman, L. P., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0368 · Cited by 162
Alkatib, A. A., Cosma, M., Elamin, M. B., Erickson, D., Swiglo, B. A., Erwin, P. J., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0672 · Cited by 147
“Arlt, 1999 (2) 24 42 Primary and secondary 50 4 Normal Bilger, 2005 (11) 5 19 Secondary 50 6 Normal Hunt, 2000 (3) 24 40 Primary 50 3 Normal Libe, 2004 (17) 7 45 Primary and secondary 50 4 Normal Lovas, 2003 (4) 36 46 Primary and secondary 25 9 Most reached normal Johannsson, 2002 (5) 38 51 Secondary 20 ( 45 yr old) o…”
BackgroundNieman, L. K., & Turner, M. L. C. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.04.006 · Cited by 149
Corona, G., Rastrelli, G., Giagulli, V. A., Sila, A., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1358 · Cited by 105
“No effect was reported on general well-being, or even on sexuality (64).”
Backgroundvon Mühlen, D. G., Laughlin, G. A., Kritz‐Silverstein, D. C., Bergstrom, J., & Bettencourt, R. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0520-z · Cited by 104
Tiemensma, J., Andela, C. D., Kaptein, A. A., Romijn, J. A., van der Mast, R. C., Biermasz, N. R., & Pereira, A. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0023 · Cited by 78
Therapeutic management of adrenal insufficiency
Hahner, S., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.009 · Cited by 61
Therapy of adrenal insufficiency: an update
Falorni, A., Minarelli, V., & Morelli, S. (2012) · Endocrine · doi:10.1007/s12020-012-9835-4 · Cited by 61
The native anti-glucocorticoid paradigm
Muller, C., Hennebert, O., & Morfin, R. F. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.03.001 · Cited by 57
Pluchino, N., Ninni, F., Stomati, M., Freschi, L., Casarosa, E., Valentino, V., Luisi, S. V., Genazzani, A. D., Potì, E., & Genazzani, A. R. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.02.004 · Cited by 44
Kluger, N., Matikainen, N., Sintonen, H., Ranki, A., Roine, R. P., & Schalin‐Jäntti, C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12484 · Cited by 41
“As demonstrated previously (4, 29, 30), DHEA supplementation was not associated with improved HRQoL in female AD patients.”
BackgroundPowrie, Y. S. L., & Smith, C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1324-0 · Cited by 38
The effects of dehydroepiandrosterone on sexual function: a systematic review
Peixoto, C., Carrilho, C. G., Barros, J. A., Ribeiro, T. T. S. B., Silva, L. M., Nardi, A. E., Cardoso, A., & Veras, A. B. (2017) · Climacteric · doi:10.1080/13697137.2017.1279141 · Cited by 30
DHEA: why, when, and how much – DHEA replacement in adrenal insufficiency
Allolio, B., Arlt, W., & Hahner, S. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.018 · Cited by 27
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00020-1 · Cited by 24
Dehydroepiandrosterone to Enhance Physical Performance: Myth and Reality
Hahner, S., & Allolio, B. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.10.008 · Cited by 17
Is DHEA replacement beneficial in chronic adrenal failure?
Lang, K., Burger‐Stritt, S., & Hahner, S. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.007 · Cited by 17
Guidelines for diagnosis and treatment of adrenal insufficiency in adults
Novoa, P. D. M., Vela, E. T., García, N. P., Rodríguez, M. M., Guerras, I. S., Santamaría, M. D. L. Á. M. D. S., & Aulinas, A. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(14)70069-8 · Cited by 16
Sexual Dysfunction in Men and Women
Bhasin, S., & Basson, R. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00020-4 · Cited by 17
Zhang, X., Huang, Y., Xu, N., Feng, W., Qiao, J., & Liu, M. R. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13997 · Cited by 11
Dehydroepiandrosterone replacement therapy
Arlt, W. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224811.39318.73 · Cited by 11
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency
Bennett, G., Cussen, L., & O’Reilly, M. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000728 · Cited by 9
Substitution mit Nebennierensteroiden
Hahner, S., & Allolio, B. (2008) · Der Internist · doi:10.1007/s00108-008-2122-z · Cited by 8
Blood lipids may have influence on the emotional well-being in young men
Kramek, E., Jastrzębska, S., Walczak-Jędrzejowska, R., Marchlewska, K., Oszukowska, E., Gumińska, A., Kula, K., & Słowikowska‐Hilczer, J. (2010) · Health · doi:10.4236/health.2010.25066 · Cited by 5
“Several studies showed the significant improvement in the emotional well-being after testosterone [9-11] or dehydroepiandrosterone sulphate (DHEA-S) administration in hypogonadal men [12,13].”
BackgroundAndrogen replacement therapy in women
Lebbe, M., Hughes, D., Reisch, N., & Arlt, W. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.45 · Cited by 7
Dehydroepiandrosterone and androstenedione
Allolio, B., Arlt, W., & Hahner, S. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.021 · Cited by 5
Digital Delivery of Meditative Movement Training Improved Health of Cigarette-Smoke-Exposed Subjects
Payne, P., Fiering, S., Zava, D. T., Gould, T. J., Brown, A., Hage, P., Gaudet, C., & Crane‐Godreau, M. A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00282 · Cited by 3
“Although there is evidence that DHEA supplementation has no significant benefits in healthy people (81), it can be of benefit in certain disorders [for example (82, 83)].”
BackgroundTherapies for adrenal insufficiency
Andrioli, M., Giraldi, F. P., Martin, M. D., & Cavagnini, F. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.11.1323 · Cited by 3
Dehydroepiandrosterone Administration in Treating Medical and Neuropsychiatric Disorders
Ritsner, M. S. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_17 · Cited by 5
Doping Status of DHEA Treatment for Female Athletes with Adrenal Insufficiency
Handelsman, D. J., Matsumoto, A. M., & GERRARD, D. F. (2016) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000300 · Cited by 3
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_7 · Cited by 2
Alesci, S., & Manoli, I. (2010) · CRC Press eBooks · doi:10.1201/b14669-30 · Cited by 1
(2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000185392.99198.0d · Cited by 1
Androgenmangel bei Frauen: Wann klinisch relevant?
Jaursch-Hancke, C. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
ENDOCRINOLOGIC EMERGENCIES IN DERMATOLOGY
Ryan, M. T., Savarese, V. W., & Jabbour, S. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511778339.032
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
New evidence for protective effects of DHEAS on health among men but not womenPreprint
Goldman, N., & Glei, D. A. (2006) · RePEc: Research Papers in Economics
Golden, W. C., Bethea, J., McGrew, M., Hadley, M., Neill, K., Dickerson, L., Simmons, H., & Stallings, J. (2010)
The role of DHEA in the aetiology of modern chronic disease
Powrie, Y. S. L. (2020) · SUNScholar (Stellenbosch University)
Trikudanathan, S., & Dluhy, R. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-560-2_2
Herbert, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00471-2 · Cited by 3
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
Faria, M. D. S., Nascimento, G. C., Faria, A. M., & Martins, M. R. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_8
Metadata
- Authors
- Libè, R., Barbetta, L., Dall’Asta, C., Salvaggio, F., Gala, C., Beck-Peccoz, P., & Ambrosi, B.
- Affiliations
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- IRCCS Policlinico San Donato (IT)
- Corresponding author
- Ambrosi, B.
- ORCID
- Dall’Asta, C.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2004-09
- Volume
- 27
- Issue
- 8
- Pages
- 736-741
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2044246760
- Semantic Scholar
- f1ee8258d2884532a8cde656574ac8aa52ea9e48
- Cited by
- 51
- References
- 31
- Citations by year
- 2023: 1 · 2022: 2 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2014: 5 · 2013: 2 · 2012: 3
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal insufficiency, Addison's disease, androgen replacement, testosterone, androstenedione, sex hormone-binding globulin, bone metabolism, osteocalcin, fat mass, lipid profile, cholesterol, insulin sensitivity, well-being, sex differences, glucocorticoid replacement therapy, mineralocorticoid replacement, self-rated health
- MeSH terms
- Addison Disease, Adrenal Insufficiency, Adult, Affect, Aged, Androstenedione, Behavior, Blood Glucose, Body Composition, Bone and Bones, Dehydroepiandrosterone, Double-Blind Method, Female, Hormones, Humans, Lipids, Male, Middle Aged, Sex Characteristics, Testosterone, Dehydroepiandrosterone Sulfate, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.